Free tool
Dividend paying stocks
We cover 66 companies that currently pay a dividend. The median market value in the group is $15.95B. Across the group, the median move over the past trading day is +0.44%. 65% of the 63 with a 200-day average trade above it. Price change over the past year runs from −23.5% to +34.8% across the middle 80 percent of the group, with a median of +2.7%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
66 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.76B | Large cap | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | $85.31B | Large cap | −38.15% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +32.17% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| SHL.DE | Siemens Healthineers AG | $51.23B | Large cap | −14.18% |
| H6D0.DE | Haleon plc | $44.85B | Large cap | +5.39% |
| HLN.L | Haleon plc | $44.62B | Large cap | +2.68% |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% |
| PHI1.DE | Koninklijke Philips N.V. | $26.37B | Large cap | +3.22% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +25.88% |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% |
| QS51.DE | Straumann Holding AG | $18.40B | Large cap | −1.10% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| SN.L | Smith & Nephew plc | $12.18B | Large cap | −22.42% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.